Small molecule conjugates with dimetal species for protein inhibition

US9045527B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9045527-B2
Application numberUS-201313916359-A
CountryUS
Kind codeB2
Filing dateJun 12, 2013
Priority dateJun 12, 2012
Publication dateJun 2, 2015
Grant dateJun 2, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for targeting a protein by providing an inhibitor covalently linked to a rhodium(II) complex, introducing the inhibitor to the target protein and allowing the inhibitor and protein to interact. The rhodium(II) complex covalently linked to the inhibitor binds the target protein both inorganically and organically and forms stabilizing secondary contacts between the rhodium(II) complex and the protein.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: introducing to a target protein a compound comprising a peptide ligand from the PDZ domain of a cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand wherein the peptide ligand is covalently linked to a rhodium(II) complex and wherein the compound binds to the target protein and form stabilizing secondary contacts between the rhodium(II) complex and the target protein. 2. A method comprising: introducing to a target protein a compound comprising a peptide covalently linked to a rhodium(II) complex, wherein the peptide comprises a sequence selected from the group consisting of SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 15, and wherein the compound binds to the target protein and forms stabilizing secondary contacts between the rhodium(II) complex and the target protein. 3. The method of claim 2 , wherein the sequence is SEQ ID NO: 7. 4. The method of claim 2 , wherein the sequence is SEQ ID NO: 8. 5. The method of claim 2 , wherein the sequence is SEQ ID NO: 15.

Assignees

Inventors

Classifications

  • C07K1/107Primary

    by chemical modification of precursor peptides · CPC title

  • C07K1/1075Primary

    by covalent attachment of amino acids or peptide residues · CPC title

  • Human Necessities · mapped topic

  • the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9045527B2 cover?
Methods for targeting a protein by providing an inhibitor covalently linked to a rhodium(II) complex, introducing the inhibitor to the target protein and allowing the inhibitor and protein to interact. The rhodium(II) complex covalently linked to the inhibitor binds the target protein both inorganically and organically and forms stabilizing secondary contacts between the rhodium(II) complex and…
Who is the assignee on this patent?
Univ Rice William M, Dartmouth College
What technology area does this patent fall under?
Primary CPC classification C07K1/107. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).